Showing results (101-110 of 159) with videos related to

Sort By:
Pageof 16
Urologic Oncology|June 17, 2017
Hilar fat infiltration: A new prognostic factor in metastatic clear cell renal cell carcinoma with first-line sunitinib treatmentSolène-Florence Kammerer-Jacquet, Angelique Brunot, Karim Bensalah, et al.
European Journal of Cancer (Oxford, England : 1990)|November 3, 2023
Hepatic arterial oxaliplatin plus intravenous 5-fluorouracil and cetuximab for first-line treatment of colorectal liver metastases: A multicenter phase II trialDavid Malka, Benjamin Verret, Matthieu Faron, et al.
International Journal of Clinical Oncology|March 28, 2020
Implementation of a molecular tumor board at a regional level to improve access to targeted therapyHéloïse Bourien, Alexandra Lespagnol, Boris Campillo-Gimenez, et al.
JHEP Reports : Innovation in Hepatology|July 28, 2026
Adjuvant capecitabine in resected biliary tract cancer: a real-world data from the BILCAP-Real study (ACABi multicentre cohort)Claire Noé, Julie Henriques, Brice Chanez, et al.
European Journal of Cancer (Oxford, England : 1990)|April 14, 2026
Efficacy of targeted therapies for metastatic small bowel adenocarcinoma treatment: A retrospective study by AGEOEmeric Boisteau, Alice Boilève, David Tougeron, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 24, 2016
A multicentre comparison between Child Pugh and Albumin-Bilirubin scores in patients treated with sorafenib for Hepatocellular CarcinomaJulien Edeline, Jean-Frédéric Blanc, Philip Johnson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 18, 2021
Modified FOLFIRINOX Versus CISGEM Chemotherapy for Patients With Advanced Biliary Tract Cancer (PRODIGE 38 AMEBICA): A Randomized Phase II StudyJean Marc Phelip, Jérôme Desrame, Julien Edeline, et al.
European Journal of Cancer (Oxford, England : 1990)|February 19, 2022
Individual patient data meta-analysis of adjuvant gemcitabine-based chemotherapy for biliary tract cancer: combined analysis of the BCAT and PRODIGE-12 studiesJulien Edeline, Satoshi Hirano, Aurélie Bertaut, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 11, 2024
Long-Term Overall Survival After Selective Internal Radiation Therapy for Locally Advanced Hepatocellular Carcinomas: Updated Analysis of DOSISPHERE-01 TrialEtienne Garin, Lambros Tselikas, Boris Guiu, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|February 21, 2023
Ipilimumab with atezolizumab-bevacizumab in patients with advanced hepatocellular carcinoma: The PRODIGE 81-FFCD 2101-TRIPLET-HCC trialPhilippe Merle, Jean-Frédéric Blanc, Julien Edeline, et al.
Pageof 16